ID
20421
Description
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Keywords
Versions (1)
- 2/22/17 2/22/17 -
Uploaded on
February 22, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Description
Invenstigator´s Declaration
Alias
- UMLS CUI-1
- C0008961
Description
Invenstigator´s Declaration
Data type
text
Alias
- UMLS CUI [1,1]
- C0008961
- UMLS CUI [1,2]
- C1442085
Description
Investigator´s signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576
Description
Date of Signature
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1519316
Similar models
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0040223 (UMLS CUI [1,2])
C1442085 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
No comments